Table 17, Sensitivity Analysis Showing Expected False-Positives, Colposcopies, CIN2-3 Cases, Cancer Cases, and Cancer Deaths Associated With Different Ages at Which to End Screening, Varying in 5-Year Increments From Age 65 to 90 Years*†‡